2-naphthoylethyltrimethylammonium has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darreh-Shori, T; Kumar, R; Långström, B | 1 |
1 other study(ies) available for 2-naphthoylethyltrimethylammonium and Alzheimer Disease
| Article | Year |
|---|---|
Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization.
Topics: Algorithms; Alzheimer Disease; Catalytic Domain; Choline O-Acetyltransferase; Cholinesterases; Humans; Inhibitory Concentration 50; Ligands; Molecular Docking Simulation; Naphthalenes; Protein Conformation; Quantitative Structure-Activity Relationship; Quaternary Ammonium Compounds; Recombinant Proteins | 2016 |